Oxurion NV (XBRU:OXUR) Beginning Cash Position : €2.18 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Oxurion NV Beginning Cash Position?

Oxurion NV's Beginning Cash Position for the quarter that ended in Dec. 2023 was €2.18 Mil.

Oxurion NV's quarterly Beginning Cash Position declined from Dec. 2022 (€3.75 Mil) to Jun. 2023 (€3.50 Mil) and declined from Jun. 2023 (€3.50 Mil) to Dec. 2023 (€2.18 Mil).

Oxurion NV's annual Beginning Cash Position declined from Dec. 2021 (€24.51 Mil) to Dec. 2022 (€9.74 Mil) and declined from Dec. 2022 (€9.74 Mil) to Dec. 2023 (€3.50 Mil).

Oxurion NV Beginning Cash Position Historical Data

The historical data trend for Oxurion NV's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Beginning Cash Position Chart

Oxurion NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

64.65

42.49

24.51

9.74

3.50

Oxurion NV Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															9.76	9.74	3.75	3.50	2.18

Oxurion NV Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Oxurion NV Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxurion NV (XBRU:OXUR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (XBRU:OXUR) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

TG4:Germany

Address

Gaston Geenslaan 1, Leuven, BEL, B-3001

Website

https://www.oxurion.com

Oxurion NV is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). The Group's research and development facilities are located in Belgium .The Company is engaged in the development of drugs to treat back-of-the-eye diseases, more specifically, ophthalmologic pharmaceuticals to treat vascular retinal disorders, specifically DME.

Oxurion NV (XBRU:OXUR) Headlines

No Headlines